Indications show the pandemic’s impact on our community’s mental health will be more widespread than the impact on our physical well-being.

Join our expert panel of mental health professionals from Australia and Israel on Monday, 7 September from 5:30-6:30pm AEST for a live webinar that explores the mental health consequences of COVID-19 and the practical ways we can support ourselves, and each other, through this crisis.


The Panel

DR RUSSELL BASSER (moderator), CHAIR OF THE HAMRC SCIENTIFIC ADVISORY COMMITTEE AND THE SENIOR VICE PRESIDENT OF R&D AT SEQIRUS, AUSTRALIA

Dr Russell Basser is Chair of the Hadassah Australia Medical Research and Collaborations Foundation's Scientific Advisory Committee and the Senior Vice President of R&D at Seqirus (a fully owned subsidiary of CSL Ltd), one of the largest influenza vaccine companies in the world and a major partner in the prevention and control of influenza globally.

In his role at Seqirus, Dr Basser is responsible for the research programs for influenza vaccine globally, and led the 2009 licensure of swine flu vaccine. His team is currently partnering with University of Queensland and the Coalition for Pandemic Preparedness Innovation (CEPI) to develop a COVID-19 vaccine that will be available globally if successful.

Prior to joining CSL, Dr Basser had a distinguished career as medical oncologist in Australia. He has an MB.BS and an MD from the University of Melbourne and is a Fellow of Royal Australasian College of Physicians.


PROF JAYASHRI KULKARNI, PROFESSOR OF PSYCHIATRY, THE ALFRED AND MONASH UNIVERSITY, MELBOURNE

Professor Kulkarni founded and directs a large psychiatric research group, the Monash Alfred Psychiatry Research Centre (MAPrc), which expanded from 25 personnel in 2002 to over 150 staff and students currently, offering seven different research streams, and conducting over 100 clinical trials.

The centre is dedicated to discovering new treatments, new understandings and new services for people with a range of mental illnesses. Professor Kulkarni became a Fellow of the Royal Australian and New Zealand College of Psychiatrists in 1989 and was awarded a PhD from Monash University in 1997 for her thesis “Women and Psychosis”.

Prof Kulkarni has pioneered the novel use of estrogen as a treatment for schizophrenia and is internationally acknowledged as a leader in the field of reproductive hormones and their impact on mental health. An expert in Women’s Mental Health, she was elected the President of the International Association of Women’s Mental Health, a role she commenced in 2017.


DR GRANT BLASHKI, LEAD CLINICAL ADVISOR, BEYOND BLUE, AUSTRALIA

Dr Grant Blashki is a practising GP, the Lead Clinical Advisor for Beyond Blue, an active media commentator, Associate Professor at the Nossal Institute for Global Health and the Melbourne Sustainable Society Institute both at The University of Melbourne, Writer in Residence at Future Leaders books, Health Ambassador for the Lord Mayor's Charitable Foundation, and Honorary Professor at Shenzhen Luohu Hospital Group in China.

His three themes of research are 1) Mental Health 2) Environmental Health and 3) Global Health. He also has expertise in Workplace Mental Health, Pandemic Mental Health Care, Genetics in Primary Care, Artificial Intelligence, and Primary Health Care in China.


PROF ESTI GALILI-WEISSTUB, DIRECTOR OF CHILD AND ADOLESCENT PSYCHIATRY, HADASSAH MEDICAL ORGANIZATION, ISRAEL

Professor Galili-Weisstub was born in Givatayim, Israel and studied medicine at the Hebrew University in Jerusalem. She completed her residency in child and adolescent psychiatry at Talbiya Mental Health Center in Jerusalem, before undertaking post graduate studies at Tel Aviv University’s Sakler Medical School. She is recognised as one of Israel’s leading child and adolescent psychiatrists and is renowned internationally for her work. Professor Galili is a past Chair of the Israeli Association of Child and Adolescent Psychiatry, a representative of child psychiatry on the Steering Committee of the National. Mental Health Reform, and a representative of child psychiatry on the Government Interdepartmental Committee dealing with issues related to suicide.

Professor Galili’s main fields of interest include emotional trauma in children and adolescents, public issues of mental health in minors, development of public services, and genetics in child psychiatry, such as PTSD, ADHD, postpartum depression and eating disorders.


DR INBAL REUVENI, HEAD OF THE WOMEN'S MENTAL HEALTH CLINIC, HADASSAH MEDICAL ORGANIZATION, ISRAEL.

Dr Reuveni is a graduate of the Joyce and Irving Goldman Medical School, Ben-Gurion, University of the Negev, Beer-Sheba, Israel. She did her residency in Adult Psychiatry at the Department of Psychiatry, Hadassah-Hebrew University Medical Center after passing her final board exams in 2013 with distinction.

Dr Reuveni started her research training in the field of biological psychiatry and neuroimaging. Her early research focused on the neurobiological imprint of exposure to trauma and post-traumatic stress disorder (PTSD). After heading the psychiatric liaison service for the Department of Obstetrics and Gynaecology at Hadassah Hebrew-University Medical Center, she founded a dedicated service within the Outpatient Mental Health Clinic to provide high-quality outpatient care for women with mood and anxiety disorders related to the reproductive life cycle, as well as women with mental health issues related to infertility, traumatic births or pregnancy loss. Her research interests have shifted accordingly, and currently focus on reproductive psychiatry and the effects of childhood trauma on the mental health of women.

Booking for this event has now closed.